ANNX

Muneer A. Satter

Known title: DirectorCIK: 0001315797

Muneer A. Satter's purchase track record

How the stock did after each of Muneer A. Satter's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
4
of 5 since July 7, 2022
Stock higher 6 months later
75%
3 months: 60%
Median 6-month return
+9.1%
3 months: +56.0%
Beat the S&P 500
50%
median +3.0% vs. index
PurchaseStockAmount3 months6 months
5/28/2026ANNX$3.32M-2.2%pending
11/17/2025ANNX$8.66M+66.9%+64.2%
12/26/2023ANNX$1.01M+56.0%+3.9%
2/10/2023ANNX$18.00M-18.1%-50.4%
7/7/2022ANNX$9.42M+61.7%+14.4%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

ANNX Listed Among Health Care Stocks Moving Pre-Market. Annexon Inc. was included in a list of health care stocks showing movement during Friday's pre-market session. The stock is currently trading near its 52-week low, with technical signals indicating a breakdown below the Bollinger Bands. Analysts maintain a wide range of price targets, reflecting uncertainty about the company's future performance.

this person other insiders at ANNX

Transaction History

ANNX▲ Buy$3.3M
ANNX▲ Buy$1.8M
ANNX▲ Buy$1.8M
ANNX▲ Buy$2.0M
ANNX▲ Buy$1.6M
ANNX▲ Buy$1.5M
ANNX▲ Buy$1.0M
ANNX▲ Buy$18.0M
ANNX▲ Buy$9.4M

We use analytics to understand how market-wall is used. No personal data is sold.